GLOBAL ONCOLOGY MONITOR
We Speak Oncology
With over 200 different types of cancer, over 60 different organs in which it can occur, and a myriad of genes and proteins that are linked to malignancies, oncology has a language of its own…
Understanding that language requires comprehensive data and a highly trained team of experts to interpret it.
We Cover Oncology
The Global Oncology Monitor is present in 20+ markets; this includes regional representation in all countries, and coverage of every practice type, small or large, in each region.
We Interpret Oncology
· Unlimited data potentialreveals patient characteristics, diagnosis, site, cell type, stage, metastases, current treatment, previous treatment, oncology adjunct product usage and adverse effects.
· Extensive applicationsinclude identifying potential, sizing the market, tracking progress, benchmarking against competitors, understanding reasons behind success / failure and designing strategy, tactics and materials to help sales forces achieve targets.
· Unsurpassed flexibilityin reporting and service comes from patient segments customised by definition, a user-friendly database, oncology analysts and customized deliverables.
We Project Oncology
Our unique annual market sizing study ensures appropriate sample coverage, and our validated projection methodology is globally applied.
We Innovate in Oncology
In addition to expanding our coverage, we are continually introducing new services – like our Molecular Diagnostics Monitor launched last year – as well as boosting our sample sizes, innovating our data collection and working with new partners. Just contact us to find out what's new.
More information about our Global Oncology Monitor
Contact David Twinberrow Tel: (8621)22319748 Email: David.Twinberrow@ipsos.com